EMED has been acquired by Tiger Infrastructure Partners

Arrowpoint Advisory’s Healthcare sector team has advised the shareholders of EMED Group, the UK’s leading specialist healthcare transport provider, on its sale to Tiger Infrastructure Partners.

Cairngorm Capital acquired E-zec in May 2021 and merged it with ERS Medical in February 2023 to create the EMED Group – now the UK’s leading specialist healthcare transport provider, three times the scale of its nearest pure-play competitor. Strategic and operational investment and a clear strategy executed by an ambitious leadership team has propelled EMED from 11 contracts and 75,000 patient journeys per month in 2021 to an impressive 87 contracts nationwide and over 176,000 journeys per month today, underpinned by significant contract wins and organic expansion into ancillary specialist services.

Dr Amit Thaper, Managing Director, who led Cairngorm Capital’s investment, commented: “EMED was a successful investment for Cairngorm Capital. Through targeted investment and strategic leadership, we unlocked EMED’s growth potential and positioned EMED as the clear market leader in specialist healthcare transport. We thank the management team, led by CEO Craig Smith, who has been instrumental in the evolution of the business and wish them every success in the future.”

He added: “The support and practical advice that Karen, Dustin and the rest of the team at Arrowpoint Advisory provided from start to finish was invaluable. They fully understood the importance of finding the right partner for the business and carefully crafted a process around that. We are delighted with the outcome.”

Michael Kerins, Chairman of EMED Group said: “EMED’s journey over the past few years has been remarkable. The dedication and expertise of Craig Smith and the entire team have been pivotal in establishing EMED as the market leader. Their unwavering focus on ‘patient-first’ operational excellence and innovation has set a strong foundation for future success.”

Craig Smith, Group CEO of EMED Group, commented: “This marks a milestone transaction for EMED as we enter the next phase of our growth journey. Huge thanks to Karen, Dustin, and the team for their invaluable support and tailored guidance throughout the process. Their approachable style and the time they invested to really develop a deep understanding of the business proved to be invaluable and I believe made a real difference. I would highly recommend their team and would welcome the opportunity to work with them again.”

Karen Dawaf, Managing Director at Arrowpoint Advisory, highlighted: “EMED is uniquely positioned to unlock access to healthcare for millions of people each year and plays an integral role in our healthcare infrastructure. This transaction delivers strong returns to Cairngorm Capital’s investors while enabling Craig and his ambitious management team to continue EMED’s impressive growth trajectory, with the strategic guidance of a new investment partner. It was a privilege to work with the team, and I look forward to seeing what’s next for EMED.”

Dustin Stevens, Director at Arrowpoint Advisory, concluded: “It has been a pleasure to have supported Craig, the EMED leadership team and Cairngorm Capital on this exciting transaction. Together they have built the leading player in the market providing a critical and essential service to the UK healthcare system. EMED is well positioned to continue growing from strength to strength, further supported by Tiger’s investment and strategic guidance, which we look forward to following with interest.”

Contact the deal team

DISCOVER our sell-side transactions